Literature DB >> 17989000

Low frequency of KIT gene mutation in pediatric acute myeloid leukemia with inv(16)(p13q22): a study of the Japanese Childhood AML Cooperative Study Group.

Akira Shimada, Hitoshi Ichikawa, Tomohiko Taki, Chisato Kubota, Teruaki Hongo, Masahiro Sako, Akira Morimoto, Akio Tawa, Ichiro Tsukimoto, Yasuhide Hayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17989000     DOI： 10.1532/IJH97.07098

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  12 in total

1.  C-kit mutations in core binding factor leukemias.

Authors:  A Beghini; P Peterlongo; C B Ripamonti; L Larizza; R Cairoli; E Morra; C Mecucci
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

2.  KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.

Authors:  Akira Shimada; Tomohiko Taki; Ken Tabuchi; Akio Tawa; Keizo Horibe; Masahiro Tsuchida; Ryoji Hanada; Ichiro Tsukimoto; Yasuhide Hayashi
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

3.  Tandem duplication of the FLT3 gene is infrequent in infant acute leukemia. Japan Infant Leukemia Study Group.

Authors:  F Xu; T Taki; M Eguchi; N Kamada; E Ishii; M Endo; Y Hayashi
Journal:  Leukemia       Date:  2000-05       Impact factor: 11.528

4.  Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.

Authors:  B F Goemans; C M Zwaan; M Miller; M Zimmermann; A Harlow; S Meshinchi; A H Loonen; K Hählen; D Reinhardt; U Creutzig; G J L Kaspers; M C Heinrich
Journal:  Leukemia       Date:  2005-09       Impact factor: 11.528

5.  Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

Authors:  Peter Paschka; Guido Marcucci; Amy S Ruppert; Krzysztof Mrózek; Hankui Chen; Rick A Kittles; Tamara Vukosavljevic; Danilo Perrotti; James W Vardiman; Andrew J Carroll; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

6.  Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

Authors:  N Boissel; H Leroy; B Brethon; N Philippe; S de Botton; A Auvrignon; E Raffoux; T Leblanc; X Thomas; O Hermine; B Quesnel; A Baruchel; G Leverger; H Dombret; C Preudhomme
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

7.  Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.

Authors:  Rory S Care; Peter J M Valk; Anne C Goodeve; Faisel M Abu-Duhier; Wendy M C Geertsma-Kleinekoort; Giu A Wilson; Mamdooh A Gari; Ian R Peake; Bob Löwenberg; John T Reilly
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

8.  Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001.

Authors:  Erik Forestier; Sverre Heim; Elisabeth Blennow; Georg Borgström; Gösta Holmgren; Kristiina Heinonen; Johann Johannsson; Gitte Kerndrup; Mette Klarskov Andersen; Catarina Lundin; Ann Nordgren; Richard Rosenquist; Birgitta Swolin; Bertil Johansson
Journal:  Br J Haematol       Date:  2003-05       Impact factor: 6.998

9.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  D Grimwade; H Walker; F Oliver; K Wheatley; C Harrison; G Harrison; J Rees; I Hann; R Stevens; A Burnett; A Goldstone
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

10.  Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.

Authors:  Ryoji Kobayashi; Akio Tawa; Ryoji Hanada; Keizo Horibe; Masahiro Tsuchida; Ichiro Tsukimoto
Journal:  Pediatr Blood Cancer       Date:  2007-04       Impact factor: 3.167
View more
  2 in total

1.  Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol.

Authors:  Hideki Nakayama; Ken Tabuchi; Akio Tawa; Ichiro Tsukimoto; Masahiro Tsuchida; Akira Morimoto; Hiromasa Yabe; Keizo Horibe; Ryoji Hanada; Masue Imaizumi; Yasuhide Hayashi; Kazuko Hamamoto; Ryoji Kobayashi; Kazuko Kudo; Akira Shimada; Takako Miyamura; Hiroshi Moritake; Daisuke Tomizawa; Takashi Taga; Souichi Adachi
Journal:  Int J Hematol       Date:  2014-06-25       Impact factor: 2.490

Review 2.  Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Authors:  Wenlan Chen; Hui Xie; Hongxiang Wang; Li Chen; Yi Sun; Zhichao Chen; Qiubai Li
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.